Increasing trend of antimicrobial drug-resistance among organism causing bacteremia in a tertiary-care hospital: 1995 to 2000;Tendencia en el incremento de la resistencia antimicrobiana en organismos causantes de bacteremia en un hospital de tercer nivel: 1995-2000

Revista de Investigacion Clinica

Volumn 55, Issue 6, 2003, Pages 600-605

  Kato Maeda, Midori ^a   Bautista Alavez, Anabertha ^a   Rolón Montes de Oca, Ana Lilia ^a   Ramos Hinojosa, Ancelmo ^a   Ponce de León, Alfredo ^a   Bobadilla del Valle, Miriam ^a   Ruiz Palacios, Guillermo ^a   Sifuentes Osornio, José ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Bacteremia; Hospital; Resistance; Trend

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; OXACILLIN; PIPERACILLIN; QUINOLONE DERIVATIVE; TIMENTIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD CULTURE; DISEASE SEVERITY; DRUG USE; ENTEROBACTER; ENTEROCOCCUS; FREQUENCY ANALYSIS; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; PSEUDOMONAS AERUGINOSA; SERRATIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TEACHING HOSPITAL;

BACTEREMIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; RETROSPECTIVE STUDIES;

EID: 1542316079     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cosgrove SE, Kaye KS, Eliopoulous GM, Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 2002; 162: 185-90.
2. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9: 1065-78.
3. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-90.
4. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001; 119: 397S-404S.
5. Haley RW, Bregman DA. The role of understaffing and over-crowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit. J Infect Dis 1982; 145: 875-85.
6. Jeljaszewics J, Mlynarczyk G, Mlynarczyk A. Antibiotic resistance in Grampositive cocci. Int J Antimicrob Agents 2000; 16: 473-8.
7. Dteinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis 2001; 33: S193-205.
8. D'Agata EM, Venkataraman L, DeGirolami P, Burke P, Eliopoulos GM, Karchmer AW, et al. Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med 1999; 27: 1090-5.
9. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-8.
10. Kollef MH. Anadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31: S131-8.
11. Urdez-Hernández E, Sifuentes-Osornio J, Calva JJ, Villalobos-Zapata Y. Epidemiological and biological characteristics of methicillin-resistant staphylococcal infections in a Mexican hospital. Arch Med Res 1999; 30: 325-31.
12. Peterson LR, Brossette SE. Hunting health care-associated infections from the clinical microbiology laboratory: passive, active, and virtual surveillance. J Clin Microbiol 2002; 40: 1-4.
13. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection control programme. Lancet 2000; 356: 1307-12.
14. Karchmer AW. Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin Infect Dis 2000; 31: S139-43.
15. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of clinical microbiology. Washington, D.C.: American Society of Microbiology; 1999.
16. Swenson JM, Hindler JA, Peterson LR. Special phenotypic methods for detecting antibacterial resistance. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington, D. C.: American Society for Microbiology; 1999, p. 1563-77.
17. Torre-Delgadillo A, Ponce de León-Garduño A, Bobadilla del Valle M, Sifuentes-Osornio J. Tipificación por campo pulsado de Pseudomonas aeruginosa aisladas de bacteremias en el INCMNSZ de 1992 al 2000. Presentado en XXVI Congreso Anual de la AMIMC 2001; Guadalajara, Jal. México. Enfermedades infecciosas y microbiología 2001; 21(Suppl.): S82.
18. Ugarte A, Ponce de León A, García-García L, Bobadilla M, Rolón AL, García C, Sifuentes-Osornio J. Caracterización de las bacteremias por enterococo en un hospital de tercer nivel. XXVII Congreso de la Asociación Mexicana de Infectología y Microbiología Clínica. Cancún, Q. R. 27 a 30 de noviembre de 2002. Enfermedades Infecciosas y Microbiología. 2002; 22(3): 87.
19. Manthous CA, Amoateng-Adjepong Y. Empiric antibiotic use and resistant microbes. A "catch-22" for the 21st Century. Chest 2000; 118: 9-11.
20. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275: 234-40.
21. Ponce de Leon S, Rangel-Frausto MS, Elias-Lopez JI, Romero-Oliveros C, Huertas-Jimenez M. Nosocomial infections: secular trends of a control program in Mexico. Sal Pub Mex 1999; 41(Suppl. 1): S5-11.
22. Boyce JM, Opal SM, Potter-Bynoe G, Medeiros AA. Spread of methicillin-resistance Staphylococcus aureus in a hospital after exposure to health care worker with chronic sinusitis. Clin Infect Dis 1993; 17: 496-504.
23. Blondeau JM. Extended-spectrum beta-lactamases. Semin Respir Infect 2001; 16: 169-76.
24. Boyce JM. Consequences of inaction: importance of infection control practices. Clin Infect Dis 2001; 33: S133-7.
25. Preston GA, Larson EL, Stamm WE. The effect of private isolation rooms on patient care practices. Colonization and infection in an intensive care unit. Am J Med 1981; 70: 641-5.